Dealings in securities by an associate of directors Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis” or “the Company”) Dealings in securities by an associate of directors In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information, relating to dealings in securities by an associate of directors, is disclosed: Directors: Gary Shayne and Crispian Dillon Name of Associate and Coast2Coast Capital Proprietary Limited (“C2C”), through a description of the transaction: subsidiary, is transferring Ascendis shares in settlement of the redemption of a debenture issued by it on 20 May 2016, at a price per share determined using the pre-agreed pricing mechanism for the debenture. Date of transaction: 6 March 2018 Class of shares: Ordinary shares Number of shares: 553,230 Price per share: R25.21 Value: R13,946,928.30 Nature of transaction: Sale, off market Nature and extent of interest: Indirect beneficial (through C2C, in which directors Gary Shayne and Crispian Dillon have an 85% and 15% indirect beneficial interest, respectively). Written clearance obtained: Clearance was obtained from the Chairman Bryanston 6 March 2018 Sponsor Questco Corporate Advisory Proprietary Limited Date: 06/03/2018 11:24:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.